Integra Lifesciences Holdings (IART) Goodwill & Intangibles (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Goodwill & Intangibles of $1.7 billion for Q1 2026, down 25.05% on a YoY basis from $2.3 billion in Q1 2025, and down 1.78% sequentially from $1.7 billion in Q4 2025.
Integra Lifesciences Holdings (IART) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Goodwill & Intangibles data on file, last reported at $1.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles fell 25.05% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 25.05% YoY), and the FY2025 full-year result was $1.7 billion, down 24.07% from the prior year.
- Goodwill & Intangibles fell to $1.7 billion in Q1 2026, from $1.7 billion in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $2.3 billion in Q3 2024 to a low of $1.7 billion in Q1 2026.
- A 5-year average of $2.1 billion and a median of $2.1 billion in 2023 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles surged 62.81% in 2022 and slipped 25.05% in 2026, its largest moves.
- Tracing IART's Goodwill & Intangibles over 5 years: stood at $2.2 billion in 2022, then slipped by 1.95% to $2.1 billion in 2023, then increased by 8.54% to $2.3 billion in 2024, then declined by 24.07% to $1.7 billion in 2025, then fell by 1.78% to $1.7 billion in 2026.
- Business Quant data shows IART's Goodwill & Intangibles at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Bn |
| Dec 31, 2025 | 1.75 Bn |
| Sep 30, 2025 | 1.78 Bn |
| Jun 30, 2025 | 1.80 Bn |
| Mar 31, 2025 | 2.29 Bn |
| Dec 31, 2024 | 2.30 Bn |
| Sep 30, 2024 | 2.33 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 2.06 Bn |
| Dec 31, 2023 | 2.12 Bn |
| Sep 30, 2023 | 2.10 Bn |
| Jun 30, 2023 | 2.14 Bn |
| Mar 31, 2023 | 2.15 Bn |
| Dec 31, 2022 | 2.17 Bn |
| Sep 30, 2022 | 2.03 Bn |
| Jun 30, 2022 | 2.07 Bn |
| Mar 31, 2022 | 2.13 Bn |
| Dec 31, 2021 | 2.16 Bn |
| Sep 30, 2021 | 2.17 Bn |
| Jun 30, 2021 | 1.27 Bn |